Table 3.
PRECIS‐2—Scoring for DREAM‐GLOBAL Study
| Domain | Criteria | Score | Rationale |
|---|---|---|---|
| 1. Eligibility Criteria | To what extent are the participants in the trial similar to those who would receive this intervention if it was part of usual care? | 3 | Participants are the same as part of usual care, and there are exclusion criteria listed |
| 2. Recruitment | How different are the settings of the trial from the usual care setting? | 2 | Community screening efforts for hypertension were held to recruit. CHRs also referred individuals to the program |
| 3. Setting | How different are the settings of the trial from the usual care setting? | 2 | Task shifting with BP measurement in community not HCP's office, some satellite sites for follow‐up visits |
| 4. Organization | How different are the resources, provider expertise, and the organization of care delivery in the intervention arm of the trial from those avail‐ able in usual care? | 2 | Due to nature of task shifting, the care is organized and delivered differently than usual care (usual care and resource has been shifted), extra training for those taking BPs |
| 5. Flexibility (delivery) | How different is the flexibility in how the intervention is delivered and the flexibility anticipated in usual care? | 3 | Flexibility in delivery of care is similar as usual care, particularly with follow‐up visits and delivery |
| 6. Flexibility (adherence) | How different is the flexibility in how participants are monitored and encouraged to adhere to the intervention from the flexibility anticipated in usual care? | 3 | Flexibility in adherence is elevated from usual care with task shifting and calls from CHR's for BP monitoring visits |
| 7. Follow‐up | How different is the intensity of measurement and follow‐up of participants in the trial from the typical follow‐up in usual care? | 2 | Follow‐up every 3 mo is likely more frequent than usual care |
| 8. Primary Outcome | To what extent is the trial's primary outcome directly relevant to participants? | 4 | Primary outcome of achieving BP control is important to participants; knowledge gained from patient perspective is also relevant |
| 9. Primary Analysis | To what extent are all data included in the analysis of the primary outcome? | 2 | BPs in primary analysis were included (no patients loss to follow‐up). First 2 and last 2 BPs used. Intermediate measures were not used for baseline or final BP. Some data not used to exclude patients with controlled BP on therapy |
1, More explanatory; 5, More pragmatic.